Showing results (81-90 of 153) with videos related to

Sort By:
Pageof 16
Liver International : Official Journal of the International Association for the Study of the Liver|November 15, 2021
Changes in therapeutic options for hepatocellular carcinoma in AsiaSadahisa Ogasawara, Keisuke Koroki, Hiroaki Kanzaki, et al.
International Journal of Molecular Sciences|January 21, 2017
Discrepancy between Hepatitis C Virus Genotypes and NS4-Based Serotypes: Association with Their Subgenomic SequencesNan Nwe Win, Shingo Nakamoto, Tatsuo Kanda, et al.
Biology|May 10, 2017
Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus RibavirinTatsuo Kanda, Masato Nakamura, Shin Yasui, et al.
World Journal of Hepatology|May 15, 2013
Platelet count and sustained virological response in hepatitis C treatmentTatsuo Kanda, Keizo Kato, Akihito Tsubota, et al.
International Journal of Medical Sciences|April 10, 2013
Efficacy of lamivudine or entecavir against virological rebound after achieving HBV DNA negativity in chronic hepatitis B patientsTomoo Miyauchi, Tatsuo Kanda, Masami Shinozaki, et al.
World Journal of Virology|July 3, 2023
Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinomaRyuta Kojima, Shingo Nakamoto, Tadayoshi Kogure, et al.
International Journal of Hepatology|December 31, 2014
IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including RegimensTatsuo Miyamura, Tatsuo Kanda, Shingo Nakamoto, et al.
International Journal of Molecular Sciences|November 26, 2014
Reactivation of hepatitis B virus in hematopoietic stem cell transplant recipients in Japan: efficacy of nucleos(t)ide analogues for prevention and treatmentShingo Nakamoto, Tatsuo Kanda, Chiaki Nakaseko, et al.
Pageof 16